Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia

MLA

Kang Fang, et al. “Targeting IGF1R Signaling Enhances the Sensitivity of Cisplatin by Inhibiting Proline and Arginine Metabolism in Oesophageal Squamous Cell Carcinoma under Hypoxia.” Journal of Experimental & Clinical Cancer Research, vol. 42, no. 1, Mar. 2023, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s13046-023-02623-2.

APA

Kang Fang, Mingchuang Sun, Zhuyun Leng, Yuan Chu, Ziying Zhao, Zhaoxing Li, Yunwei Zhang, Aiping Xu, Zehua Zhang, Li Zhang, Tao Chen, & Meidong Xu. (2023). Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia. Journal of Experimental & Clinical Cancer Research, 42(1), 1–18. https://doi.org/10.1186/s13046-023-02623-2

Chicago

Kang Fang, Mingchuang Sun, Zhuyun Leng, Yuan Chu, Ziying Zhao, Zhaoxing Li, Yunwei Zhang, et al. 2023. “Targeting IGF1R Signaling Enhances the Sensitivity of Cisplatin by Inhibiting Proline and Arginine Metabolism in Oesophageal Squamous Cell Carcinoma under Hypoxia.” Journal of Experimental & Clinical Cancer Research 42 (1): 1–18. doi:10.1186/s13046-023-02623-2.